Dopamine agonists and risk of lung cancer in patients with restless legs syndrome.

Published in: Pharmacoepidemiology and drug safety (2023)

At typical doses for the clinical management of RLS, long-term DA use was not associated with risk of lung cancer.

Keyphrases